Morehouse School of Medicine SNRP

莫尔豪斯医学院 SNRP

• 批准号: 8574241
• 负责人: PETER RAYMOND MACLEISH
• 金额: $ 139.51万
• 依托单位: MOREHOUSE SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-08-15 至 2018-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8574241
• 关键词: Acids; Animal Model; Basic Science; Betaine; Chromosome Mapping; Combined Modality Therapy; Critiques; Deterioration; Development; Disease; Effectiveness; Environment; Faculty; Fenofibrate; Genetic; Goals; Individual; Institutes; Institution; Ions; Leadership; Mediating; Medical; Mission; Morehouse School of Medicine; National Institute of Neurological Disorders and Stroke; Neurons; Neurosciences; Neurosciences Research; Outcome; Phenotype; Physiological; Population; Postdoctoral Fellow; Readiness; Regulator Genes; Research; Research Training; Resources; Role; Services; Signal Pathway; Signal Transduction; Sleep; Sleep Disorders; Strategic Planning; Students; Subarachnoid Hemorrhage; Testing; Training; Translational Research; burden of illness; career; comparative; graduate student; nervous system disorder; novel; programs; public health relevance; tool

DESCRIPTION (provided by applicant): Morehouse School of Medicine (MSM) is a young and dynamic institution with a strong mission of service to the underserved through the training of medical and scientific professionals and through the focused development of a basic and translational research environment dedicated to exploring mechanisms of disorders with high disease burden in populations served by the institution. In keeping with the intent of the RFA and consistent with its internal strategic plan, the MSM Neuroscience Institute proposes to augment and strengthen its research programs focused on NINDS mission related research and to increase the academic preparedness of students from diverse backgrounds for advanced Neuroscience research careers. In this application, we proposed three exploratory projects that focus on: (1) Identifying new genetic targets to help treat sleep disorders (Project 1, Pi's Paul and DeBruyne). In this project, the Pi's will combine a well-established paradigm of comparative phenotyping of a genetically tractable animal model with powerful genetic mapping tools to identify novel sleep-regulatory gene; (ii) Understanding the role of Acid Sensing Ion Chanel 1a (ASICIa) -mediated signaling pathways in neurons (Project 2, PI Xiong). In this proposal, the PI will define ASICIa-mediated signaling cascades in physiological- and pathophysiological conditions; and (iii) The effectiveness of a combination therapy against delayed neuronal deterioration after subarachnoid hemorrhage (Project 3, PI Namura). This project will test the hypothesis that the combination of betaine (trimethylglycine) and fenofibrate may be a potential strategy for treating this neurological disease. Two other objectives of the application are (i) to train and develop a competitive cadre of neuroscientists from underrepresented groups by providing tools to enhance the competiveness of Neuroscience Institute faculty; and (11) to provide training opportunities for graduate students and postdoctoral fellows and to expand the pool of undergraduates exposed to competitive Neuroscience research. To accomplish the above goals, we will provide effective administrative and scientific resource cores to facilitate the goals of this application.

描述（由申请人提供）：莫尔豪斯医学院（MSM）是一个年轻而充满活力的机构，通过医疗和科学专业人员的培训，并通过专注于基础和转化研究环境的重点发展，为服务不足的人提供强大的使命，致力于探索该机构服务的人群中疾病负担高的疾病机制。与RFA的意图保持一致，并与其内部战略计划一致，MSM神经科学研究所建议增加和加强其研究计划，重点是NINDS使命相关的研究，并增加来自不同背景的学生的学术准备先进的神经科学研究事业。在这项申请中，我们提出了三个探索性的项目，重点是：（1）确定新的基因靶点，以帮助治疗睡眠障碍（项目1，Pi的保罗和德布鲁因）。在这个项目中，PI将联合收割机结合一个成熟的范式，比较表型的一个遗传听话的动物模型与强大的遗传作图工具，以确定新的睡眠调节基因;（ii）了解酸敏感离子通道1a（ASICIa）介导的信号通路在神经元中的作用（项目2，PI熊）。在本提案中，PI将定义生理和病理生理条件下ASICIa介导的信号级联;（iii）蛛网膜下腔出血后联合治疗对迟发性神经元退化的有效性（项目3，PI Namura）。本项目将测试甜菜碱（三甲基甘氨酸）和非诺贝特的组合可能是治疗这种神经系统疾病的潜在策略的假设。申请的另外两个目的是（i） 通过提供工具，以提高神经科学研究所教师的竞争力，从代表性不足的群体中培养和发展神经科学家的竞争力骨干;（11）为研究生和博士后研究员提供培训机会，并扩大本科生接触竞争性神经科学研究的人数。为了实现上述目标，我们将提供有效的行政和科学资源核心，以促进本申请的目标。